01 1Raks Pharma
01 1PROCHLORPERAZINE EDISYLATE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-05-10
Pay. Date : 2019-03-26
DMF Number : 33693
Submission : 2019-03-28
Status : Active
Type : II
20
Raks Pharma Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is PROCHLORPERAZINE EDISYLATE USP, with a corresponding US DMF Number 33693.
Remarkably, this DMF maintains an Active status since its submission on March 28, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 10, 2019, and payment made on March 26, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
